Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-26T22:21:27.313Z Has data issue: false hasContentIssue false

Lithium augmentation in antidepressant-resistant patients

Published online by Cambridge University Press:  02 January 2018

G. M. Goodwin
Affiliation:
MRC Brain Metabolism Unit, Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF
F. G. M. Souza
Affiliation:
MRC Brain Metabolism Unit, Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF
M.-P. Austin
Affiliation:
Mood Disorders Unit, Prince Henry Hospital, 2036 Sydney, Australia
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

References

Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet, 339, 115.Google Scholar
Georgotas, A., McCue, R., Hapworth, W. et al (1986) Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biological Psychiatry, 21, 11551166.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.Google Scholar
Quttkin, F. M., Rabkin, J. G., Ross, D., et al (1984) Duration of antidepressant drug treatment. What is an adequate trial? Archives of General Psychiatry, 41, 238245.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.